Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Author Archives: Admin

Sona Nanotech Announces Validation Results for its COVID-19 Antigen Test

July 2, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid detection, COVID-19 antigen test’s laboratory validation studies of performance levels … Read More

Sona Nanotech Inc. participates in the Coronavirus Virtual Webinar Series

Sona Nanotech Inc. is proud to be a participant of the Coronavirus Virtual Webinar Series, an online-only event occurring on June 17, 2020. A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health … Read More

Sona Nanotech Comments on Trading Activity at Request of IIROC

Sona Nanotech Comments on Trading Activity at Request of IIROC June 1, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) has been requested by the Investment Industry Regulatory Organization of Canada (IIROC) to comment … Read More

Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies

Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies May 22, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to … Read More

Sona Nanotech Provides Covid-19 Antigen Test Progress Update

May 12, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to provide the following update on the development of its rapid-response, Covid-19 antigen test.  The Company received confirmation from an independent laboratory … Read More

Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test

April 13, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test.  The Company this past week has: … Read More

Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test

March 31, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the “Company”) is pleased to announce that it has been awarded a $4.1 million grant from NGen, Canada’s Advanced Manufacturing Supercluster, to develop and commercialize … Read More

Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests

March 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the “Company”) entered into service and supply agreements with a contract manufacturing organization (CMO) in Europe for the manufacture of its Covid-19 virus-detecting, rapid-response test.  … Read More

SONA NANOTECH OBTAINS NEW OTC TRADING SYMBOL

SONA NANOTECH OBTAINS NEW OTC TRADING SYMBOL March 20, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA, OTC Pink: SNANF) (the “Company”) is pleased to announce that it has undertaken to further develop the U.S. trading market for … Read More

Sona Achieves Significant Milestone in Covid-19 Test Development

Halifax, Nova Scotia, March 19, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) (OTC: LMTCF) is pleased to provide an update on the development of its rapid-response Covid-19 test.  Sona is leading a consortium of diagnostic test developers including GE … Read More